Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

Also called NCT03025971

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 107 participants (enrolled count) (from the registry)
Sponsor
JC Medical, Inc., an affiliate of Edwards Lifesciences LLC (from the registry)
Registry
  • NCT NCT03025971
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03025971. Allocation not applicable; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation
Condition
Aortic Valve Disease
Intervention (Device)
J-Valve Transcatheter Aortic valve replacement
Lead sponsor
JC Medical, Inc., an affiliate of Edwards Lifesciences LLC (class: industry)

Record details

Record id
cardio:ct-nct03025971
Content hash
a201bcc4e5c962e49f4bfdee5129a840773866933f08f54a2a3118d219f52750